By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > News > Purdue Pharma allowed to shield Sackler owners from opioid lawsuits
News

Purdue Pharma allowed to shield Sackler owners from opioid lawsuits

News Room
Last updated: 2023/05/30 at 1:03 PM
By News Room
Share
4 Min Read
SHARE

Members of the Sackler family who own Purdue Pharma can be shielded from lawsuits linked to the US opioid crisis in exchange for payments worth up to $6bn, appellate judges have ruled in a reversal of a lower court’s decision.

The judgment addresses a controversial provision of US law that released Sackler family owners of Purdue from liability as part of the company’s bankruptcy settlement. The maker of the powerful painkiller OxyContin, Purdue filed for bankruptcy in New York in 2019 amid a wave of litigation over its role in an opioid epidemic that has killed almost 1mn people in the US.

A bankruptcy judge in 2021 approved a settlement that required the family owners to pay $4.5bn and provided them with immunity from future lawsuits. A federal judge overturned that settlement later that year.

The company’s Sackler owners then agreed to increase their financial contribution from $4.5bn to $6bn, winning support from several dissident victims groups and states which had opposed the original deal.

On Tuesday a three-judge panel of the US Court of Appeals for the Second Circuit reversed the lower court’s decision and said that bankruptcy law permitted giving civil liability protection to parties who are not in bankruptcy in certain situations.

“The bankruptcy court’s inclusion of the releases is equitable and appropriate under . . . the specific factual circumstances,” Judge Eunice Lee wrote in a majority opinion.

The announcement paves the way for the bankruptcy court to approve a modified settlement that would protect the Sackler family from lawsuits.

The bankruptcy trustee, a division of the Department of Justice that had opposed the releases, declined to comment on whether it would appeal against the ruling to the Supreme Court.

Such releases have become controversial in US bankruptcy cases, with appeals courts in different regions or legal circuits differing on whether to approve them.

Purdue’s initial $4.5bn settlement was thrown out following a legal appeal by a group of eight US states and the attorney for the Southern District of New York, which had argued that Sackler family owners were benefiting from the bankruptcy process without having personally filed for Chapter 11 protection themselves.

Opponents of the original settlement pointed to analysis presented in the bankruptcy court that showed the Sackler family members who own Purdue had taken more than $10bn out of the company between 2008 and 2017.

Lawyers for Purdue warned that without such a settlement, years of litigation would delay payments to victims and shrink the available pot.

In a statement, the families of the late Mortimer Sackler and the late Raymond Sackler said on Tuesday that they “believe the long-awaited implementation of this resolution is critical to providing substantial resources for people and communities in need. We are pleased with the court’s decision to allow the agreement to move forward and look forward to it taking effect as soon as possible.”

Read the full article here

News Room May 30, 2023 May 30, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
How AI Is Changing Shopping

Watch full video on YouTube

Nvidia Q3 earnings: Why the setup for Nvidia is looking very good ‘from multiple angles’

Watch full video on YouTube

Meridian Corporation Justifies Greater Upside From Here (NASDAQ:MRBK)

This article was written byFollowDaniel is an avid and active professional investor.…

What economists got wrong in 2025

Welcome back. As this is my last edition before the new year,…

Inside America’s Race To Build The Next Generation Of AI Chips

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

News

Meridian Corporation Justifies Greater Upside From Here (NASDAQ:MRBK)

By News Room
News

What economists got wrong in 2025

By News Room
News

Quanex Building Products Corporation (NX) Q4 2025 Earnings Call Transcript

By News Room
News

Europe’s rocky relations with Donald Trump

By News Room
News

Crypto founder Do Kwon sentenced to 15 years in prison

By News Room
News

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Phase 1a Single-Ascending and Multiple-Ascending Dose Data – Slideshow (NASDAQ:CRBP) 2025-12-11

By News Room
News

Disney to invest $1bn into OpenAI

By News Room
News

Freedom for Venezuela coming ‘soon’, says opposition leader

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?